Details for New Drug Application (NDA): 091248
✉ Email this page to a colleague
The generic ingredient in MYCOPHENOLATE SODIUM is mycophenolate sodium. There is one drug master file entry for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the mycophenolate sodium profile page.
Summary for 091248
| Tradename: | MYCOPHENOLATE SODIUM |
| Applicant: | Rk Pharma |
| Ingredient: | mycophenolate sodium |
| Patents: | 0 |
Suppliers and Packaging for NDA: 091248
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| MYCOPHENOLATE SODIUM | mycophenolate sodium | TABLET, DELAYED RELEASE;ORAL | 091248 | ANDA | Archis Pharma LLC | 72819-155 | 72819-155-08 | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (72819-155-08) |
| MYCOPHENOLATE SODIUM | mycophenolate sodium | TABLET, DELAYED RELEASE;ORAL | 091248 | ANDA | Archis Pharma LLC | 72819-156 | 72819-156-08 | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (72819-156-08) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | EQ 360MG BASE | ||||
| Approval Date: | Jan 8, 2014 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | EQ 180MG BASE | ||||
| Approval Date: | Jan 8, 2014 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
